IOSP trades 40.6% below Wall Street's consensus target of $110.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes IOSP achieves its forward estimates and maintains a stable P/E multiple of 15.9x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Innospec Inc. (IOSP) has a Wall Street consensus price target of $110.00, based on estimates from 9 covering analysts. With the stock currently trading at $78.21, this represents a potential upside of +40.6%. The company has a market capitalization of $1.93B.
Analyst price targets range from a low of $110.00 to a high of $110.00, representing a 0% spread in expectations. The median target of $110.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, IOSP trades at a trailing P/E of 13.8x and forward P/E of 15.9x. The forward PEG ratio of 0.49 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -13.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $92.50, with bear and bull scenarios of $58.28 and $121.88 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HWKNHawkins, Inc. | $3.2B | $150.95 | $157.00 | +4.0% | Buy | 38.4x | 2 |
 BCPCBalchem Corp | $5.6B | $174.43 | $212.50 | +21.8% | Buy | 31.8x | 10 |
 ITICInvestors Title Company | $484M | $256.37 | — | — | — | 42.1x | — |
 KWRQuaker Houghton | $2.6B | $150.02 | $186.33 | +24.2% | Buy | 18.8x | 16 |
 CBTCabot Corp. | $3.7B | $71.05 | $94.00 | +32.3% | Buy | 11.2x | 16 |
 ASIXAdvanSix Inc. | $453M | $16.82 | $30.80 | +83.1% | Buy | 90.9x | 7 |
 ALBAlbemarle Corporation | $11.7B | $99.25 | $167.09 | +68.4% | Buy | 9.0x | 46 |
 ECLEcolab Inc. | $84.6B | $300.68 | $328.00 | +9.1% | Buy | 36.9x | 37 |
 IFFInternational Flavors & Fragrances Inc. | $21.1B | $82.62 | $98.14 | +18.8% | Buy | 24.7x | 34 |
 TROXTronox Holdings plc | $400M | $2.51 | $5.86 | +133.5% | Hold | — | 17 |
Quick answers to the most common questions about buying IOSP stock.
The consensus Wall Street price target for IOSP is $110, representing 40.6% upside from the current price of $78.21. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
IOSP has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $110 implies 40.6% upside from current levels.
With a forward P/E of 15.857x, IOSP trades at a relatively low valuation. The consensus target of $110 implies 40.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $110 for IOSP, while the most conservative target is $110. The consensus of $110 represents the median expectation. Our quantitative valuation model projects a bull case target of $122 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
IOSP is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month IOSP stock forecast based on 9 Wall Street analysts shows a consensus price target of $110, with estimates ranging from $110 (bear case) to $110 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $93, with bear/bull scenarios of $58/$122.
Our quantitative valuation model calculates IOSP's fair value at $93 (base case), with a bear case of $58 and bull case of $122. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
IOSP trades at a forward P/E ratio of 15.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on IOSP, with a "Hold" consensus rating and $110 price target (40.6% upside). 4 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
IOSP analyst price targets range from $110 to $110, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $110 consensus represents the middle ground. Our model's $58-$122 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.